A microsatellite polymorphism in intron 2 of human Toll-like receptor 2 gene: Functional implications and racial differences

FEMS Immunology and Medical Microbiology

Volumn 40, Issue 2, 2004, Pages 163-169

  Yim, Jae Joon ^a   Ding, Li ^b   Schäffer, Alejandro A ^c   Park, Gye Young ^d   Shim, Young Soo ^a   Holland, Steven M ^b  

^a Seoul National University College of Medicine   (South Korea)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d Gachon University   (South Korea)

Author keywords

GM CSF; Interferon ; Microsatellite polymorphism; Toll like receptor 2

Indexed keywords

DINUCLEOTIDE; GAMMA INTERFERON; MICROSATELLITE DNA; RECOMBINANT DNA; REPETITIVE DNA; RIBONUCLEOTIDE; TOLL LIKE RECEPTOR 2;

AFRICAN AMERICAN; ALLELE; ARTICLE; BACTERIAL INFECTION; CAUCASIAN; CELLULAR IMMUNITY; DINUCLEOTIDE REPEAT; DNA FLANKING REGION; GENE ACTIVITY; GENE CONSTRUCT; GENE FUNCTION; GENETIC POLYMORPHISM; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; INFLAMMATION; INTRON; KOREA; MYCOBACTERIUM; PATHOGENESIS; PRIORITY JOURNAL; RACE DIFFERENCE; REPORTER GENE; TRANSLATION INITIATION;

EID: 1342281646     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(03)00342-0     Document Type: Article

References (44)

1. Kopp E.B., Medzhitov R. The Toll-receptor family and control of innate immunity. Curr. Opin. Immunol. 11:1999;13-18.
2. Aderem A., Ulevitch R.J. Toll-like receptors in the induction of the innate immune response. Nature. 406:2000;782-787.
3. Medzhitov R., Janeway C.A. Jr. Innate immunity: the virtues of a nonclonal system of recognition. Cell. 91:1997;295-298.
4. Medzhitov R., Janeway C.A. Jr. Innate immunity: impact on the adaptive immune response. Curr. Opin. Immunol. 9:1997;4-9.
5. Hoffmann J.A., Kafatos F.C., Janeway C.A., Ezekowitz R.A. Phylogenetic perspectives in innate immunity. Science. 284:1999;1313-1318.
6. Medzhitov R., Janeway C.A. Jr. Innate immune recognition: mechanisms and pathways. Immunol. Rev. 173:2000;89-97.
7. Schnare M., Barton G.M., Holt A.C., Takeda K., Akira S., Medzhitov R. Toll-like receptors control activation of adaptive immune responses. Nat. Immunol. 2:2001;947-950.
8. Medzhitov R., Preston-Hurlburt P., Janeway C.A. Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature. 388:1997;394-397.
9. Rock F.L., Hardiman G., Timans J.C., Kastelein R.A., Bazan J.F. A family of human receptors structurally related to Drosophila Toll. Proc. Natl. Acad. Sci. USA. 95:1998;588-593.
10. Takeuchi O., Hoshino K., Kawai T., Sanjo H., Takada H., Ogawa T., Takeda K., Akira S. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity. 11:1999;443-451.
11. Yoshimura A., Lien E., Ingalls R.R., Tuomanen E., Dziarski R., Golenbock D. Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J. Immunol. 163:1999;1-5.
12. Schwandner R., Dziarski R., Wesche H., Rothe M., Kirschning C.J. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J. Biol. Chem. 274:1999;17406-17409.
13. Brightbill H.D., Libraty D.H., Krutzik S.R., Yang R.-B., Belisle J.T., Bleharski J.R., Maitland M., Norgard M.V., Plevy S.E., Smale S.T., Brennan P.J., Bloom B.R., Godowski P.J., Modlin R.L. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science. 285:1999;732-736.
14. Werts C., Tapping R.I., Mathison J.C., Chuang T.H., Kravchenko V., Saint Girons I., Haake D.A., Godowski P.J., Hayashi F., Ozinsky A., Underhill D.M., Kirschning C.J., Wagner H., Aderem A., Tobias P.S., Ulevitch R.J. Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat. Immunol. 2:2001;346-352.
15. May M.J., Ghosh S. Signal transduction through NF-κB. Immunol. Today. 19:1998;80-88.
16. Kirschning C.J., Wesche H., Merrill Ayres T., Rothe M. Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide. J. Exp. Med. 188:1998;2091-2097.
17. Yang R.-B., Mark M.R., Gurney A.L., Godowski P.J. Signaling events induced by lipopolysaccharide-activated toll-like receptor 2. J. Immunol. 163:1999;639-643.
18. Takeuchi O., Hoshino K., Akira S. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J. Immunol. 165:2000;5392-5396.
19. Lorenz E., Mira J.P., Cornish K.L., Arbour N.C., Schwartz D.A. A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect. Immun. 68:2000;6398-6401.
20. Kang T.-J., Chae G.-T. Detection of Toll-like receptor 2 (TLR2) mutation in the lepromatous leprosy patients. FEMS Immunol. Med. Microbiol. 31:2001;53-58.
21. Haehnel V., Schwarzfischer L., Fenton M.J., Rehli M. Transcriptional regulation of the human toll-like receptor 2 gene in monocytes and macrophages. J. Immunol. 168:2002;5629-5637.
22. Pravica V., Asderakis A., Perrey C., Hajeer A., Sinnott P.J., Hutchinson I.V. In vitro production of IFN-γ correlates with CA repeat polymorphism in the human IFN-γ gene. Eur. J. Immunogenet. 26:1999;1-3.
23. Khani-Hanjani A., Lacaille D., Hoar D., Chalmers A., Horsman D., Anderson M., Balshaw R., Keown P.A. Association between dinucleotide repeat in non-coding region of interferon-gamma gene and susceptibility to, and severity of, rheumatoid arthritis. Lancet. 356:2000;820-825.
24. Cavet J., Dickinson A.M., Norden J., Taylor P.R., Jackson G.H., Middleton P.G. Interferon-γ and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation. Blood. 98:2001;1594-1600.
25. Dabora S.L., Roberts P., Nieto A., Perez R., Jozwiak S., Franz D., Bissler J., Thiele E.A., Sims K., Kwiatkowski D.J. Association between a high-expressing interferon-γ allele and a lower frequency of kidney angiomyolipomas in TSC2 patients. Am. J. Hum. Genet. 71:2002;750-758.
26. Masutani K., Miyake K., Nakashima H., Hirano T., Kubo M., Hirakawa M., Tsuruya K., Fukuda K., Kanai H., Otsuka T., Hirakata H., Iida M. Impact of interferon-γ and interleukin-4 gene polymorphisms on development and progression of IgA nephropathy in Japanese patients. Am. J. Kidney Dis. 41:2003;371-379.
27. Bellamy R., Ruwende C., Corrah T., McAdam K.P.W.J., Whittle H.C., Hill A.V. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N. Engl. J. Med. 338:1998;640-644.
28. Burgner D., Xu W., Rockett K., Gravenor M., Charles I.G., Hill A.V., Kwiatkowski D. Inducible nitric oxide synthase polymorphism and fatal cerebral malaria. Lancet. 352:1998;1193-1194.
29. Yamada N., Yamaya M., Okinaga S., Nakayama K., Sekizawa K., Shibahara S., Sasaki H. Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. Am. J. Hum. Genet. 66:2000;187-195.
30. Benjafield A.V., Wang X.L., Morris B.J. Tumor necrosis factor receptor 2 gene (TNFRSF1B) in genetic basis of coronary artery disease. J. Mol. Med. 79:2001;109-115.
31. Mellick G.D., Buchanan D.D., Silburn P.A., Chan D.K.Y., Le Couteur D.G., Law L.K., Woo J., Pang C.P. The monoamine oxidase B gene GT repeat polymorphism and Parkinson's disease in a Chinese population. J. Neurol. 247:2000;52-55.
32. Hjelmström P., Peacock C.S., Giscombe R., Pirskanen R., Lefvert A.K., Blackwell J.M., Sanjeevi C.B. Polymorphism in tumor necrosis factor genes associated with myasthenia gravis. J. Neuroimmunol. 88:1998;137-143.
33. Ikegishi Y., Tawata M., Aida K., Onaya T. Z-4 allele upstream of the aldose reductase gene is associated with proliferative retinopathy in Japanese patients with NIDDM, and elevated luciferase gene transcription in vitro. Life Sci. 65:1999;2061-2070.
34. Warpeha K.M., Xu W., Liu L., Charles I.G., Patterson C.C., Ah-Fat F., Harding S., Hart P.M., Chakravarthy U., Hughes A.E. Genotyping and functional analysis of a polymorphic (CCTTT)n repeat of NOS2A in diabetic retinopathy. FASEB J. 13:1999;1825-1832.
35. Maeda S., Haneda M., Guo B., Koya D., Hayashi K., Sugimoto T., Isshiki K., Yasuda H., Kashiwagi A., Kikkawa R. Dinucleotide repeat polymorphism of matrix metalloproteinase-9 gene is associated with diabetic nephropathy. Kidney Int. 60:2001;1428-1434.
36. Shimajiri S., Arima N., Tanimoto A., Murata Y., Hamada T., Wang K-Y., Sasaguri Y. Shortened microsatellite d(CA)21 sequence down-regulates promoter activity of matrix metalloproteinase 9 gene. FEBS Lett. 455:1999;70-74.
37. Sajantila A., Pacek P., Lukka M., Syvänen A.-C., Nokelainen P., Sistonen P., Peltonen L., Budowle B. A microsatellite polymorphism in the von Willebrand factor gene: comparison of allele frequencies in different population samples and evaluation for forensic medicine. Forensic Sci. Int. 68:1994;91-102.
38. Watkins W.S., Bamshad M., Jorde L.B. Population genetics of trinucleotide repeat polymorphisms. Hum. Mol. Genet. 4:1995;1485-1491.
39. Xu W., Humphries S., Tomita M., Okuyama T., Matsuki M., Burgner D., Kwiatkowski D., Liu L., Charles I.G. Survey of the allelic frequency of a NOS2A promoter microsatellite in human populations: assessment of the NOS2A gene and predisposition to infectious disease. Nitric Oxide. 4:2000;379-383.
40. Stead W.W., Senner J.W., Reddick W.T., Lofgren J.P. Racial differences in susceptibility to infection by Mycobacterium tuberculosis. N. Engl. J. Med. 322:1990;422-427.
41. Goh K.-L., Parasakthi N. The racial cohort phenomenon: seroepidemiology of Helicobacter pylori infection in a multiracial South-East Asian country. Eur. J. Gastroenterol. Hepatol. 13:2001;177-183.
42. Lanciers S., Hauser B., Vandenplas Y., Blecker U. The prevalence of Helicobacter pylori positivity in asymptomatic children of different ethnic backgrounds living in the same country. Ethn. Health. 1:1996;169-173.
43. Ballou S.P., Khan M.A., Kushner I. Clinical features of systemic lupus erythematosus: differences related to race and age of onset. Arthritis Rheum. 25:1982;55-60.
44. Wang F., Wang C.L., Tan C.T., Manivasagar M. Systemic lupus erythematosus in Malaysia: a study of 539 patients and comparison of prevalence and disease expression in different racial and gender groups. Lupus. 6:1997;248-253.